GIP receptor activation may contribute to improved metabolic function, while GLP-1 receptor agonism primarily mediates appetite suppression through central nervous system pathways affecting satiety centers in the hypothalamus
In animals, obesity does not impair GIP or GLP-1 secretion from isolated perfused preparations of small intestine, and weight loss does not influence GLP-1 secretion [57]
Patients of childbearing potential should also receive counseling on contraception and planned pregnancy, since the review notes limited pregnancy data and recommends stopping GLP-1RAs at least two months before planned conception
Lilly intends to seek regulatory approval for the indication
GP, GL, VC, and VL contributed to the clinical follow-up of patients
Months 612 People often continue losing weight at a steady but slower pace